Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy

This study aims to investigate the correlation between paclitaxel-induced neuropathy and the measurement values of serum IL-20 levels at baseline and during chemotherapy in patients who will receive neoadjuvant or adjuvant paclitaxel chemotherapy with the diagnosis of early-stage or locally advanced breast cancer

Inclusion Criteria:patients receiving paclitaxel chemotherapy for local advanced or early-stage breast cancer>18 yearsExclusion Criteria:advanced stage breast cancerhaving before peripheral neuropathypatients with diabetes mellitus< 18 years